baber/WOPTO huggingface dataset:
Patent MX-154192-A (MX)
Inventor: DELASSUS JUAN
IPC: B22D11/12
Filed: 1981-11-23
Abstract: A translating field inductor for the stirring roller of a continuous slab caster includes a grooved arbor carrying flat magnetic sheets disposed parallel to the axis of the arbor, the latter and the sheets being notched by a series of circumferential grooves spaced over the length of the arbor and housing circular induction coils. In order to concentrate the magnetic flux on the moving slab in the course of the continuous casting, the arbor is stationary and is made of a nonmagnetic metal with good electrical conductivity. It has a longitudinal groove with a wide transverse cross section housing a single packet of sheets, which constitutes the magnetic core of the inductor. The arbor forms a screen for the magnetic flux generated by the induction coils with the entire assembly being such that the magnetic flux is oriented in a fixed, prescribed direction.
Patent NZ-208691-A (NZ)
Title: Dihydrodibenzocycloheptylidene-ethylpiperazine derivatives and pharmaceutical compositions thereof
Inventor: CIRERA X D
IPC: C07D307/52
Filed: 1984-06-28
Abstract: New compounds derived from diphenyl-methylene-ethylamine of the following structural formula I: 
<CHEM>
 as well as their pharmaceutically acceptable salts and other derivatives, including N-oxydes and quaternary ammonium salts, possessing properties for the treatment of various pathological conditions and pains; their method of preparation; pharmaceutical compositions containing the said compounds; and the treatment of various pathological conditions and pains with the use of the said composition.
Patent NZ-210371-A (NZ)
Title: B-((halobenzyl)-phenoxy)-ethylamine derivatives and pharmaceutical compositions
Inventor: LACOLLE J-Y
IPC: A61K31/13
Filed: 1984-11-28
Abstract: This invention is concerned with new  beta -[2-(halogenobenzyl)-phenoxy]-ethylamine derivatives of the general formula    <IMAGE>  (I)  wherein R represents a C1-C8-alkyl group having a linear or branched hydrocarbon chain, R1 and R2, which may identical or different, represent each a C1-C4-alkyl-group, and Ar represents a polychlorophenyl group of the formula    <IMAGE> (II) (in which Y1 is 4-Cl, Y2 is H or Cl, and Y3 is H or Cl, at least one of the Y2 and Y3 being Cl); and their addition salts. These new compounds are useful as pharmaceuticals.
Patent NZ-216957-A (NZ)
Title: Catalyst for hydrocarbon conversion using oxides of mn, nb or lanthanides
Inventor: KOLTS J H
IPC: B01J23/34
Filed: 1986-07-24
Abstract: Compositions of matter, including: A mixture of at least one oxide of manganese and at least one oxide of a Lanthanum Series metal, preferably lanthanum or cerium, or at leaat one oxide of niobium. The above compositions are particularly useful as catalytic compositions for the conversion of C<sub>3</sub> and C<sub>4</sub> hydrocarbons to less saturated hydrocarbons, particularly ethylene and propylene and preferably ethylene. The life of the catalyst for the selective production of ethylene is extended by carrying out the reaction in the presence of steam. The steam substantially increases the active life of the catalytic composition, before regeneration is necessary, as well as significantly increasing the selectivity to ethylene. Limiting the amount of "bound" or "fixed" sulfur in the catalytic composition also improves the catalyst.
Patent NZ-226245-A (NZ)
Title: Extended release preparation comprising metoprolol and a dihydropyridine; process for manufacture
Inventor: RAGNARSSON GERT ANDERS
IPC: A61K9/22
Filed: 1988-09-20
Abstract: Preparation giving a controlled and extended release of both a dihydropyridine, e.g. felodipine and a  beta -adrenoreceptor antagonist, namely metoprolol as well as a method for the manufacture of the new preparation.
Patent NZ-228625-A (NZ)
Title: Flavonoid compounds, preparation and pharmaceutical compositions thereof
Inventor: BRIET PHILIPPE
IPC: C07D311/92
Filed: 1989-04-05
Abstract: Substituted flavonoid compounds of the formula (I): <CHEM> are disclosed. These compounds possess anticancer activity, in particular antipancreatic cancer activity, together with immunomodulatory activity.
Patent NZ-239477-A (NZ)
Title: Shaped articles of a thermoplastic melt of destructurised starch
Inventor: COLE EWART THOMAS
IPC: A61K9/52
Filed: 1991-08-20
Abstract: Shaped articles, as obtained from a thermoplastic melt, which melt comprises a medium and a phase, the medium functioning as a dispersion medium with respect to the phase, the phase likewise functioning as a disperse phase with respect to the medium, the phase being present in the thermoplastic melt at a concentration sufficient to effect an increase in dissolution of said articles by comparison with the rate of dissolution of articles made from a thermoplastic melt absent said phase, said medium consisting of a melt comprising destructurised starch and said phase comprising at least a hydrophilic material.
Patent NZ-243131-A (NZ)
Title: Soft lens prepared from alkoxylated glucose or sucrose polymers; prepolymers and preparation thereof
Inventor: NUNEZ IVAN M
IPC: C08G18/50
Filed: 1992-06-12
Abstract: A low water contact lens material having high 0<6> permeability, a lower water content and reduced polymer matrix size provides adequate O<6> to the cornea, but does not wick water away from the eye nor allow protein or other tear components to penetrate and deposit in the lens. Such a lens is made by polymerizing and crosslinking a prepolymer which contains a cyclic polyol with polyalkylether segments containing curable segments. The cyclic polyols consist of alkoxylated glucose or sucrose which are then reacted with an isocyanate to produce an ultraviolet curable prepolymer. The prepolymer is then placed in a mold and polymerized by exposure to ultraviolet light. The free hydroxyl groups of the material react with a highly hydrophilic reagent to form covalent bonds thus making the surface of the material more wettable.
Patent NZ-250438-A (NZ)
Title: Substituted benzoylguanidines, preparation and medicaments thereof
Inventor: WEICHERT ANDREAS
IPC: A61K31/155
Filed: 1993-12-13
Abstract: Benzoylguanidines of the formula I <IMAGE>     where R(1) is hydrogen, Hal, -NO2, -CN, -CF3, R(4)-SOm or R(5)R(6)N-SO2-, where m is zero to 2, R(4) and R(5) are alk(en)yl or -CnH2n-R(7), n is zero to 4, with R(5) also having the meaning of H, and R(6) is H or (C1-C4)-alkyl, with R(5) and R(6) together being able to be 4 or 5 methylene groups,   R(2) is -SR(10), -OR(10), -NHR(10), -NR(10)R(11), -CHR(10)R(12), <IMAGE>     with R(10) and R(11) being identical or different and being -[CHR(16)]s-(CH2)p-(CHOH)q-(CH2)r-(CH2OH)t-R(21) or -(CH2)p-O(CH2-CH2O)q-R(21), R(12) and R(13) being hydrogen or alkyl, or forming a cycloalkyl together with the carbon atom carrying them,   R(14) being H, (cyclo)alkyl or -CnH2n-R(15),   R(3) is defined as R(1) or is alkyl, hydrogen or -X-R(22), where X is oxygen, S or NR(16),  are described, as are the pharmaceutically tolerated salts thereof. The compounds I possess very good anti-arrhythmic properties but do not have any undesirable salidiuretic properties. In addition to this, they are notable for their strong inhibitory effect on the proliferation of cells.
Patent NZ-258392-A (NZ)
Title: Chimeric and radiolabelled antibodies to the b lymphocyte cellsurface antigen bp35 (cd-20) and their use in the treatment of b cell lymphona
Inventor: ANDERSON DARRELL R
IPC: C12P21/08
Filed: 1993-11-12
Abstract: Disclosed herein is an immunologically active, chimeric anti-CD20 antibody for use as a medicament, which antibody is capable of substantial B-cell depletion when administered to a subject.
Patent NZ-277969-A (NZ)
Title: Transdermal drug delivery system containing a drug and a visible indicator
Inventor: ROYDS ROBERT BRUCE
IPC: A61K9/70
Filed: 1994-12-09
Abstract: In a transdermal drug delivery system, encapsulation material used to coat drug granules controls the release of an active ingredient. The active ingredient is released into a water retaining matrix, which acts as a reservoir, and transdermal drug penetration is driven by the resulting concentration gradient. The delivery system is enclosed in a patch comprising a composite shell, which acts as an occlusive covering when attached to skin, thus enhancing the hydration of the skin area and fostering absorption of the drug. Visible change indicators incorporated into the system provide indicators at significant "landmarks" in the lifetime of the patch. Microcapsules used for the indicator may be formulated so that the penetration of moisture effects a color change at a time when the active ingredient is almost exhausted. This feature alerts to the user to the need for application of a replacement patch.
Patent NZ-287190-A (NZ)
Title: Device for compression of the lumbar spine comprising a waistcoat and a foot plate with pulling cords therebetween
Inventor: WILLEN JAN A G
IPC: A61B5/055
Filed: 1995-05-24
Abstract: PCT No. PCT/SE95/00581 Sec. 371 Date Jan. 24, 1996 Sec. 102(e) Date Jan. 24, 1996 PCT Filed May 24, 1995 PCT Pub. No. WO95/31936 PCT Pub. Date Nov. 30, 1995The present invention relates to a device for use in medical procedures for imaging a patient's lumbar spine while in a supine position by computerized tomography and magnetic resonance tomography, comprising a garment-like structure such as waistcoat substantially surrounding a portion of the body of a patient, a foot plate having pressure sensors and being attached to a substantially stationary surface, a pulling cord attached to said waistcoat and said foot plate as well as a transmission attached to said pulling cord and said foot plate for exerting a pressure on the spine.
Patent NZ-293541-A (NZ)
Title: Synergistic hydration compositions comprising hydrastis canadensis (golden seal), ulmus fulva (slippery elm) and smilax ornata (sarsaparilla)
Inventor: BOUBLIK JAROSLAV H
IPC: A61K36/49
Filed: 1995-10-06
Abstract: A hydration composition for the body is provided which essentially includes the synergistic combination of: (a) Hydrastis canadensis (common name: Golden Seal), b) Ulmus fulva (common name: Slippery Elm), and (c) Smilax ornata (common name: Salsaparilla). The above hydration composition may be prepared in homoeopathic or non-homocopathic form. The homoeopathic hydration composition may be prepared by any one of the following methods comprising: (i) forming separate homoeopathic preparations from components (a, b and c) mentioned hereinabove, and subsequently mixing said homoeopathic preparations; (ii) mixing extracts of components (a, b and c) and forming the resultant mixture into a homoepathic composition; and (iii) preparing a first homoeopathic composition as in (i) and (ii) above (with optional additional ingredients), and further diluting said first composition to form a second homoeopathic composition.
Patent NZ-303096-A (NZ)
Title: Method and apparatus for determining the potential fouling effect of a feedstream by passing sample through filter of known properties
Inventor: BECK THOMAS WILLIAM
IPC: B01D65/02
Filed: 1996-03-15
Abstract: A method of monitoring and controlling a filtering system, said method comprising the steps of:  i) determining resistance values of filtering elements used in the filtering system (5) at predetermined times during the backwash cycle of the system by monitoring a number of operating parameters of the system;  ii) calculating a backwash efficiency value representative of the efficiency of the backwash cycle of the filtering system (5) using the resistance values determined in i); and  iii) controlling the operation of the filtering system in dependence on the value of the backwash efficiency calculated.
Patent NZ-332485-A (NZ)
Title: Stretched plastic film for agricultural use which in use allows penetration of seedling plant
Inventor: JOHNSTONE PETER
IPC: A01G13/02
Filed: 1997-05-01
Abstract: There is disclosed the provision of a plastic film for covering soil for use in cropping or covering a frame for greenhouse effect, wherein at least part of the film has been stretched beyond its yield point prior to application.  In use the reduced thickness and/or deterioration of the film allows the passage of a germinated seedling plant, while providing a "greenhouse effect".
Patent NZ-334154-A (NZ)
Title: Cross-protective equine herpes virus (EHV-1) vaccine that protects against EHV-1 and EHV-4 and method of making and using the same
Inventor: MACEK JOSEPH
IPC: A61P15/06
Filed: 1997-08-05
Abstract: A monovalent inactivated EHV-1 vaccine which provides protection against respiratory diseases associated with EHV-1 and EHV-4 comprising an EHV-1 virus represented by strain AB 69 which is designated as ATCC VR-2581. The vaccine is prepared by infecting a susceptible cell line from equines with EHV-1 virus, allowing the virus to grow in a growth-supporting media until a significant CPE is produced, harvesting the media containing the EHV-1 virus, dead cells, cell debris and infected cells to produce a harvest material, inactivating the harvest with beta propiolactone, or formalin or binary ethylenimine, and adjuvanting the inactivated harvest material selected from polymers, oils, aluminium salts, cytokines, and immunodmodulators.
Patent NZ-503679-A (NZ)
Title: Preparation of (lB,4R)-cis-4- [2-amino-6-chloro-9R-purin- 9-yl] -2-cyclopentene-1-methanol hydrochloride salt.
Inventor: JONES MARTIN FRANCIS
IPC: C07D473/40
Filed: 1998-10-14
Abstract: Described is a process for the preparation of a carbocyclic purine nucleoside analogue of formula (I), its salts and pharmaceutically acceptable derivatives thereof which comprises hydrolysing a compound of formula (IV) wherein P is a protecting group, in the presence of an acid, condensing the product of formula (V) formed in situ in the presence of a base with a compound of formula (VI) followed by in situ ring closure of the resulting intermediate.
Patent NZ-507928-A (NZ)
Title: Bacterial identification assay using bacteriophages and colony growth measurements
Inventor: HYMAN LIZBETH JANE
IPC: A01N63/00
Filed: 1999-04-30
Abstract: An assay for the typing of bacterial strains comprising: (a) providing an isolated colony of bacteria; (b) combining said isolated colony with a selected bacteriophage in a container, then incubating in a medium containing the nutrients required for bacterial growth, and which enables phage/bacteria interaction; and (c) determining the extent of bacterial growth compared to a control sample, and comparing the value obtained to predetermined growth data for known bacteria with said bacteriophage, thereby identifying the bacteria. A method of using said assay to select bacteriophages that work against specific bacterial species is also covered.
Patent NZ-508035-A (NZ)
Title: New drug combinations of A N.A.R.I., namely reboxetine and pindolol
Inventor: TAYLOR DUNCAN PAUL
IPC: A61K31/535
Filed: 1999-04-14
Abstract: A product comprising pindolol and reboxetine, said combination increasing the rapid-acting onset of activity of the reboxetine drug.
Patent NZ-510400-A (NZ)
Title: Sustained release preparation of lipophilic drugs in which the excessive initial drug release is suppressed and a sustained release is effected
Inventor: SANO AKIHIKO
IPC: A61K9/26
Filed: 1999-09-06
Abstract: A sustained release preparation of a fat-soluble  drug comprising  a  drug dispersion wherein the fat-soluble  drug and  a  water-soluble substance are dispersed,  in  a  solid state  at  the  bodily temperature of the  animal  or  human being to which the preparation is to be administered,  in  a water-impermeable and biocompatible material
Patent NZ-513115-A (NZ)
Title: Anticonvulsant derivatives useful in treating cluster headaches
Inventor: CARRAZANA ENRIQUE
IPC: A61K31/35
Filed: 2000-01-13
Abstract: The use of anticonvulsant derivatives of formula (I) for treating cluster headaches is disclosed, wherein X is CH2 or oxygen; R1 is hydrogen or C1-C4 alkyl; and R2, R3, R4 and R5 are independently hydrogen or C1-C3 alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benzene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group of formula (II), wherein R6 and R7 are the same or different and are hydrogen, C1-C3 alkyl or R6 and R7 together with the carbon to which they are attached are joined to form a cyclopentyl or cyclohexyl ring.
Patent NZ-514340-A (NZ)
Title: Early detection of inflammation and infection using infrared thermography
Inventor: SCHAEFER ALLAN L
IPC: G01N25/72
Filed: 2000-03-22
Abstract: The present invention provides a method for the detection of inflammation in animals using infrared thermography. The invention also provides a method for the detection of diseases or disorders that induce inflammation using infrared thermography. The present invention further provides a method for the detection of infections in animals using infrared thermography.
Patent NZ-514768-A (NZ)
Title: 4-phenylpiperidine (such as paroxetine) alkane or phenyl sulphonate derivatives useful for treating pain
Inventor: BENNEKER FRANCISCUS BERNARDUS
IPC: C07D211/22
Filed: 1997-06-10
Abstract: Crystalline paroxetine methane sulfonate, crystalline paroxetine benzene sulfonate Crystalline paroxetine p-toluene sulfonate, and/or crystalline paroxetine p-chlorobenzene sulfonate.  Processes for preparing these compounds and pharmaceutical compositions containing them.  Also described is the use of these compounds in the treatment of depression (including depression arising from pre0menstrual tension), obsessive compulsive disorder, panic disorder, bulimia, anorexia, pain, obesity, senile dementia, migraine, and social phobia.
Patent NZ-518872-A (NZ)
Title: Air conditioning unit hung on window ledge.
Inventor: FORKOSH MORDECHAI
IPC: F24F13/32
Filed: 1998-11-11
Abstract: An air-conditioning apparatus enclosure 112 within which air is conditioned, and having an air inlet and an air outlet, is hung on the window 114 ledge118. A first conduit 14 has an entrance for air and an exit communicating with the inlet of the conditioner enclosure and a second conduit 15 (not shown) has an exit and an entrance communicating with the outlet of the conditioner enclosure. Stale air is piped from within the room to the air conditioning unit hung on the window ledge on the outside of the building and conditioned air is piped into the room via the second conduit from the conditioning unit.
Patent NZ-518883-A (NZ)
Title: Rotatable drum for heating bulk honey
Inventor: BRAY PETER RICHARD
IPC: A23L5/30
Filed: 2002-05-10
Abstract: Apparatus for heating a viscous liquid contained in a drum, the apparatus including: support means adapted to support a drum lying with its longitudinal axis horizontal or at an acute angle to the horizontal, the support means being adapted to rotate the drum about its longitudinal axis; and heating means external to the drum for applying heat to the exterior of the drum while the drum is being rotated. Also described is a method of heating honey contained in a drum, the method including: (i) Providing the apparatus as described above. (ii) Supporting the drum upon the support means. (iii)Driving the support means to rotate the drum about its longitudinal axis whilst applying heat to the drum by the heating means.
Patent NZ-519937-A (NZ)
Title: A method and an arrangement for detecting and discharging misplaced boards at a separation elevator
Inventor: LOVKVIST HAKAN
IPC: B65G47/14
Filed: 2000-12-11
Abstract: A method and a device for detection and removal of one or more misplaced boards (6) on an elevator for the separation of boards (6). The elevator comprises a frame (1) that supports carrier chains (2) that run over pulley wheels (3) and demonstrate carriers (2.1) on which boards (6) are lifted. The elevator comprises removal devices (5.3, 5.4) for misplaced boards (6). Removal of two or more boards that have been lifted together on one row of equivalently placed carriers (2.1) is achieved with the aid of at least one laser-light detector. Laser light is directed towards the long sides of the boards (6) and reflected laser light is received in the relevant detector. The signals from each detector are processed in a computer and the boards (6) removed from the elevator with the aid of a removal device (5.3, 5.4) if misplaced are registered by the computer.
Patent NZ-528697-A (NZ)
Title: Novel PRO362 polypeptides and nucleic acids encoding same with homology to A33 antigen and HCAR membrane bound protein
Inventor: WOOD WILLIAM I
IPC: C12N15/62
Filed: 1999-03-08
Abstract: An isolated nucleic acid having at least 80% sequence identity to a nucleotide sequence that encodes a polypeptide designated PRO363 comprising the amino acid sequence SEQ ID NO:52. Preferably the nucleic acid comprises the sequence of SEQ ID NO:51 or is that deposited under accession number ATCC 209620. Vectors, isolated host cells, processes for preparing the polypeptide and antibodies are also described. (62) Divided out of 507435
Patent NZ-531018-A (NZ)
Title: 5-CNAC as oral delivery agent for parathyroid hormone fragments
Inventor: AZRIA MOISE
IPC: A61P5/18
Filed: 2002-08-16
Abstract: A pharmaceutical composition comprises a PTH fragment and 5-CNAC for oral delivery. The PTH fragment is selected from PTH (1-28) to PTH (1-41). The composition is useful for stimulating new bone formation and the treatment or prevention of osteoporosis.
Patent NZ-531260-A (NZ)
Title: Treatment of cardiac arrhythmias using oxabispidine compounds
Inventor: BJORE ANNIKA
IPC: C07D519/00
Filed: 2000-10-13
Abstract: Described are combinations of oxabispidine compounds of formula I, for which the substituents are defined herein, and any other drug useful in the treatment of cardiovascular disorders such as arrhythmias. (62) Divided out of 518156
Patent NZ-531263-A (NZ)
Title: Use of cetrorelix to induce an enhanced or decreased immune response without lowering sex hormones to levels below castration level
Inventor: ENGEL JURGEN
IPC: A61P19/02
Filed: 2002-07-30
Abstract: Described is the use of appropriate doses of cetrorelix (an LHRH-antagonist) to lower sex hormone levels resulting in an enhancement or a decrease in the T-cell population in an individual suffering from a disease that will respond favourably to such modification. The preferred dosage range is from 5 mg to 120 mg over a period of 1 to 8 weeks.
Patent NZ-532265-A (NZ)
Title: Single strength juice deacidification by ion-exchange column
Inventor: CHUNG YONGSOO
IPC: A23L5/20
Filed: 2002-09-20
Abstract: A process for de-acidifying single strength juice, including not from concentrate (NFC) juice, uses an ion-exchange column. The process includes flowing water into the resin column and draining a fraction of the water from the column to create a head space in the column above the resin beads. Single strength juice is then introduced into the head space and into the resin column. Water is drained from the column until an SOI criteria is met. Single strength juice continues to be introduced into the resin column and treated liquid is directed to the production of de-acidified single strength juice, typically until such time as the acidity of the treated liquid exceeds a pre-determined value. Treated single strength juice is removed from the resin column to create a head space in the column. Water then is introduced into the head space and liquid passes through the exit port.
Patent NZ-532972-A (NZ)
Title: Package formed from sheet material including lines of weakness to allow opening by tearing
Inventor: MULDER BARRY
Filed: 2004-05-17
Abstract: Packages formed by joining two wall portions 1, 2 made from a tearable sheet material are disclosed. The wall portions are joined along one or more boundary lines 17, 18 between the package wall 28 and peripheral margin portions 19, 20. Two portions of the boundary line form an acute angle which embraces part of the marginal portion. Each marginal portion is partially severed along a sever line 22, 23 that does not intersect the boundary line. One end of the sever line lies between the boundary line portions forming the acute angle. The package may be opened by tearing along a sever line.